activity
20152020
most citedMassively Multitask Networks for Drug Discovery

408 citations · 464 across the 3 of their papers we have counts for

collaborators

6 papers

cs.LG202026 cited

Pursuing a Prospective Perspective

Steven Kearnes

Retrospective testing of predictive models does not consider the real-world context in which models are deployed. Prospective validation, on the other hand, enables meaningful comp…

q-bio.QM2020

Machine learning on DNA-encoded libraries: A new paradigm for hit-finding

Kevin McCloskey, Eric A. Sigel, Steven Kearnes +16

DNA-encoded small molecule libraries (DELs) have enabled discovery of novel inhibitors for many distinct protein targets of therapeutic value through screening of libraries with up…

cs.LG201930 cited

Decoding Molecular Graph Embeddings with Reinforcement Learning

Steven Kearnes, Li Li, Patrick Riley

We present RL-VAE, a graph-to-graph variational autoencoder that uses reinforcement learning to decode molecular graphs from latent embeddings. Methods have been described previous…

cs.LG2018

Optimization of Molecules via Deep Reinforcement Learning

Zhenpeng Zhou, Steven Kearnes, Li Li +2

We present a framework, which we call Molecule Deep -Networks (MolDQN), for molecule optimization by combining domain knowledge of chemistry and state-of-the-art reinforcement l…

cs.LG2018

Tensor field networks: Rotation- and translation-equivariant neural networks for 3D point clouds

Nathaniel Thomas, Tess Smidt, Steven Kearnes +4

We introduce tensor field neural networks, which are locally equivariant to 3D rotations, translations, and permutations of points at every layer. 3D rotation equivariance removes…

stat.ML2015408 cited

Massively Multitask Networks for Drug Discovery

Bharath Ramsundar, Steven Kearnes, Patrick Riley +3

Massively multitask neural architectures provide a learning framework for drug discovery that synthesizes information from many distinct biological sources. To train these architec…